Ionis Pharmaceuticals Inc Capital Reinvestment Ratio
Ionis Pharmaceuticals Inc capital reinvestment ratio. Ionis Pharmaceuticals Inc (IONS) has a Capital Reinvestment Ratio of 0.03x as of June 2026, meaning it reinvests 0% of its operating cash flow ($565.53 Million) in capital expenditures ($16.08 Million). See IONS FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Ionis Pharmaceuticals Inc (2007–2021)
Capital reinvestment ratio of Ionis Pharmaceuticals Inc from 2007 to 2021. This chart tracks Ionis Pharmaceuticals Inc's Capital Reinvestment Ratio across 11 annual periods. See Ionis Pharmaceuticals Inc (IONS) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Ionis Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2007–2021)
Ionis Pharmaceuticals Inc capital reinvestment ratio by year from 2007 to 2021. For the full cash flow conversion analysis, see Ionis Pharmaceuticals Inc cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.58x | $30.80 Million | $17.90 Million | ▼ -49.2% |
| 2020 | 1.14x | $35.89 Million | $41.05 Million | ▲ +989.8% |
| 2019 | 0.10x | $345.72 Million | $36.28 Million | ▲ +258.4% |
| 2018 | 0.03x | $602.89 Million | $17.65 Million | ▼ -86.5% |
| 2017 | 0.22x | $174.15 Million | $37.86 Million | ▼ -60.9% |
| 2015 | 0.56x | $21.12 Million | $11.75 Million | ▼ -68.5% |
| 2014 | 1.77x | $6.29 Million | $11.10 Million | ▲ +1992.1% |
| 2013 | 0.08x | $63.49 Million | $5.36 Million | ▼ -96.9% |
| 2012 | 2.76x | $1.88 Million | $5.17 Million | ▲ +3323.7% |
| 2008 | 0.08x | $212.03 Million | $17.07 Million | ▼ -42.0% |
| 2007 | 0.14x | $36.09 Million | $5.01 Million | — |